News report
綠葉製藥肺癌新藥Zepzelca在港澳上市：為小細胞肺癌患者帶來新希望
癌症患者免疫力下降易生蛇，症狀包括神經痛、水泡，易與癌症痛症混淆。李宇聰醫生建議化療前接種新一代重組生蛇疫苗，非活體疫苗更安全，保護率87.7%，保護...
Read more >>
Yen Cheng-kuo passed away from lung adenocarcinoma | Dr. Li Yu Chung, Jacky analyzes 6 high-risk factors, survival rates, and the latest treatment options
台灣男星顏正國肺腺癌離世，確診不足1年。香港聯合腫瘤中心李宇聰醫生解析本港肺癌致命率達66%，每年5,707人確診。詳解6大高危人士、3種警號徵狀、4...
Read more >>
肺腺癌5大高危與先兆，醫生拆解最新治療
肺腺癌屬亞洲人頭號殺手，由臨床腫瘤科專科醫生詳細拆解五大高危群組與三大早期警號，並分析最新標靶及免疫治療方案。立即點擊閱讀專家建議，守護肺部健康。
Read more >>
Sing Tao Front Page Exclusive Interview: 55% of New Lung Cancer Cases Are at Advanced Stages, Personalized Therapy Helps Reduce Recurrence Risk
Sing Tao Daily invited Dr. Li Yu Chung, Jacky to analyze lung cancer treatment trends. In 2022, 55% of new lung cancer cases reached stage IV, with a stage I survival rate of 72.4% compared to stage III's 24.6%. The Hong Kong United Cancer Centre provides genetic testing guidance...
Read more >>